You have 1 free searches left this month | for more free features.

Phase III trial

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lung Cancer Trial in Arlington, Dallas (carboplatin, paclitaxel, sorafenib tosylate)

Withdrawn
  • Lung Cancer
  • Arlington, Texas
  • +1 more
Jan 8, 2019

Autism Spectrum Disorder Trial in Phoenix (Wide-spectrum nutritional supplement, Placebo)

Active, not recruiting
  • Autism Spectrum Disorder
  • Wide-spectrum nutritional supplement
  • Placebo
  • Phoenix, Arizona
    Southwestern Research & Resource Center
Sep 26, 2022

Viral and Epigenetic Influences in CRSwNP

Recruiting
  • Chronic Rhinosinusitis (Diagnosis)
  • Endoscopic sinus surgery (ESS)
  • Montréal, Quebec, Canada
    CHUM
May 19, 2023

Solid Tumor, NSCLC, Cervical Cancer Trial in China (Afuresertib, Nab paclitaxel, Docetaxel)

Recruiting
  • Solid Tumor
  • +5 more
  • Beijing, Beijing, China
  • +4 more
Jul 15, 2022

Bullous Pemphigoid Trial (dupilumab)

Temporarily not available
  • Bullous Pemphigoid
  • (no location specified)
Jun 7, 2023

Premature Birth, Parenteral Nutrition, Motor Disorders Trial in Almería (Neurodevelopmental stimulation + Oral stimulation, Oral

Enrolling by invitation
  • Premature Birth
  • +4 more
  • Neurodevelopmental stimulation + Oral stimulation
  • Oral stimulation
  • Almería, Spain
    University Hospital Torrecardenas
Nov 8, 2022

Brain Tumor, Metabolic Disturbance, Inflammatory Response Trial in Thessaloniki (Dexmedetomidine, Normal saline)

Completed
  • Brain Tumor
  • +3 more
  • Thessaloniki, Greece
    AHEPA University Hospital
Feb 14, 2022

Danon Disease Trial in La Jolla, Philadelphia (RP-A501)

Recruiting
  • Danon Disease
  • RP-A501
  • La Jolla, California
  • +1 more
Oct 17, 2023

ARDS Trial in Tel-Aviv (EXO-CD24, Placebo)

Recruiting
  • ARDS
  • Tel-Aviv, Israel
    Tel-Aviv Sourasky Medical Center
Jul 7, 2023

SARS-CoV-2 Infection Trial in Baltimore (B/HPIV3/S-6P)

Recruiting
  • SARS-CoV-2 Infection
  • B/HPIV3/S-6P
  • Baltimore, Maryland
    Johns Hopkins Bloomberg School of Public Health
Aug 30, 2023

Hepatocellular Carcinoma Trial in Hangzhou (PM8002, FOLFOX regimen)

Recruiting
  • Hepatocellular Carcinoma
  • PM8002
  • FOLFOX regimen
  • Hangzhou, Zhejiang, China
    Cancer Hospital of The University of Chinese Academy of Sciences
May 19, 2023

Rhinitis Trial in Muang (Cleanoze®, Saline (Syringe irrigation))

Completed
  • Rhinitis
  • Muang, Khonkaen, Thailand
    Department of Otolaryngology, Khonkaen University
Aug 7, 2018

CDED in a Real World IBD Clinic

Recruiting
  • Crohn Disease
    • Tel Aviv, Israel
    • +1 more
    Oct 11, 2022

    Bladder Urothelial Carcinoma In Situ, Infiltrating Bladder Mixed Carcinoma, Stage 0a Bladder Cancer AJCC v8 Trial in Guam,

    Recruiting
    • Bladder Urothelial Carcinoma In Situ
    • +4 more
    • Gemcitabine Hydrochloride
    • Pembrolizumab
    • Birmingham, Alabama
    • +379 more
    Aug 23, 2022

    Acute Myelogenous Leukemia, AML Trial in Worldwide (Venetoclax, Cytarabine)

    Completed
    • Acute Myelogenous Leukemia
    • AML
    • Kansas City, Kansas
    • +8 more
    Aug 3, 2022

    Ketamine Causing Adverse Effects in Therapeutic Use Trial in Assiut (Ketamine 0.1 mg, Ketamine 0.2 mg, Ketamine 0.3 mg)

    Recruiting
    • Ketamine Causing Adverse Effects in Therapeutic Use
    • Ketamine 0.1 mg
    • +2 more
    • Assiut, Egypt
      Assiut University hospital
    Apr 17, 2022

    Langerhans Cell Histiocytosis, LCH Trial (FCN-159)

    Not yet recruiting
    • Langerhans Cell Histiocytosis
    • LCH
    • (no location specified)
    Aug 15, 2023

    Acute Myeloid Leukemia, Myelodysplasia Trial in Roma (Haplo SCT with NK cells, Haplo SCT)

    Recruiting
    • Acute Myeloid Leukemia
    • Myelodysplasia
    • Haplo SCT with NK cells
    • Haplo SCT
    • Roma, RM, Italy
      Fondazione Policlinico Universitario A. Gemelli IRCCS
    Oct 14, 2021

    Prostate Cancer Trial in Rome (Decapeptyl)

    Recruiting
    • Prostate Cancer
    • Rome, Lazio, Italy
    • +2 more
    Sep 23, 2022

    COVID-19 Infection Trial (WPV01, Placebo)

    Not yet recruiting
    • COVID-19 Infection
    • (no location specified)
    Mar 1, 2023

    Locally Advanced Unresectable or Metastatic Solid Tumor Trial in China, United States (SIM0237)

    Recruiting
    • Locally Advanced Unresectable or Metastatic Solid Tumor
    • Indianapolis, Indiana
    • +7 more
    Mar 10, 2023

    GVHD Trial in Worldwide (Begelomab, Conventional Second-line Treatment)

    Terminated
    • Graft vs Host Disease
    • Begelomab
    • Conventional Second-line Treatment
    • Duarte, California
    • +26 more
    Jan 20, 2020

    Raynaud Phenomenon Secondary to Systemic Sclerosis Trial in Paris (BOTOX® solution, Placebo group)

    Completed
    • Raynaud Phenomenon Secondary to Systemic Sclerosis
    • BOTOX® solution
    • Placebo group
    • Paris, France
      Hôpital Tenon
    Feb 9, 2022

    Paroxysmal Nocturnal Hemoglobinuria Trial in China (Eculizumab)

    Not yet recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • Beijing, China
    • +6 more
    May 24, 2023

    Disfigurement of Face Trial in New York (Face recognition task)

    Enrolling by invitation
    • Disfigurement of Face
    • Face recognition task
    • New York, New York
      New York University School of Medicine
    Sep 7, 2022